Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Total Current Liabilities (2018 - 2025)

Exagen (XGN) has disclosed Total Current Liabilities for 8 consecutive years, with $14.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 4.83% year-over-year to $14.2 million, compared with a TTM value of $14.2 million through Dec 2025, up 4.83%, and an annual FY2025 reading of $14.2 million, up 4.83% over the prior year.
  • Total Current Liabilities was $14.2 million for Q4 2025 at Exagen, up from $12.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $14.2 million in Q4 2025 and bottomed at $7.9 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $10.4 million, with a median of $9.8 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities fell 22.01% in 2023, then surged 59.34% in 2025.
  • Year by year, Total Current Liabilities stood at $9.3 million in 2021, then increased by 3.27% to $9.6 million in 2022, then grew by 23.68% to $11.9 million in 2023, then grew by 13.48% to $13.5 million in 2024, then rose by 4.83% to $14.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for XGN at $14.2 million in Q4 2025, $12.9 million in Q3 2025, and $10.3 million in Q2 2025.